On Tuesday, 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) was -15.51% drop from the session before settling in for the closing price of $3.16. A 52-week range for SXTP has been $1.41 – $35.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 43.88% over the past five years. When this article was written, the company’s average yearly earnings per share was at 81.77%. With a float of $1.38 million, this company’s outstanding shares have now reached $1.47 million.
Let’s look at the performance matrix of the company that is accounted for 3 employees. In terms of profitability, gross margin is 39.69%, operating margin of -1522.88%, and the pretax margin is -1247.06%.
60 Degrees Pharmaceuticals Inc (SXTP) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward 60 Degrees Pharmaceuticals Inc stocks. The insider ownership of 60 Degrees Pharmaceuticals Inc is 6.27%, while institutional ownership is 2.08%. The most recent insider transaction that took place on Dec 13 ’24, was worth 9,375. In this transaction Director of this company bought 6,000 shares at a rate of $1.56, taking the stock ownership to the 52,078 shares. Before that another transaction happened on Dec 12 ’24, when Company’s Director bought 5,000 for $1.82, making the entire transaction worth $9,125. This insider now owns 46,078 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 71.59% during the next five years compared to 12.29% growth over the previous five years of trading.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
You can see what 60 Degrees Pharmaceuticals Inc (SXTP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -27.07, a number that is poised to hit -1.31 in the next quarter and is forecasted to reach -3.23 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) saw its 5-day average volume 0.53 million, a negative change from its year-to-date volume of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 36.71%. Additionally, its Average True Range was 0.54.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 11.41%, which indicates a significant decrease from 37.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 242.09% in the past 14 days, which was higher than the 180.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.24, while its 200-day Moving Average is $5.62. Nevertheless, the first resistance level for the watch stands at $3.86 in the near term. At $5.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.67. If the price goes on to break the first support level at $2.05, it is likely to go to the next support level at $1.42. Assuming the price breaks the second support level, the third support level stands at $0.24.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
There are 1,473K outstanding shares of the company, which has a market capitalization of 3.93 million. As of now, sales total 680 K while income totals -7,950 K. Its latest quarter income was 260 K while its last quarter net income were -2,050 K.
